David Vizcaya, PhD

Senior epidemiologist
Bayer Pharmaceuticals, Spain

Dr David Vizcaya holds a PhD in biomedicine and a master's in public health from Unversity Pompeu Fabra, Spain. David started his career in environmental and occupational epidemiology in Barcelona and Montreal. Since 2015 he works as epidemiologist at the pharmaceuticals division of Bayer supporting global activities in the cardiovascular therapeutic area. Currently he is located in the Barcelona area.

Poster(s):

• (130) Baseline characteristics of patients with chronic kidney disease and type 2 diabetes (CKD-T2D) initiating anti-hyperglycemic medication: differences before and during the outbreak of COVID-19 in US and UK
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (148) Understanding the journey and complications in patients with type 2 diabetes from the US and the UK: an OMOP-based data network analysis
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (167) Heart failure burden in patients with incident CKD in the US: a multi-database FOUNTAIN analysis
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (169) Treatment with antidiabetics in patients with T2D and moderate to severe CKD: a multi-database FOUNTAIN analysis
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (186) FOUNTAIN: a modular research platform for Integrated Real-World Evidence Generation
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT